Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
15 participants
OBSERVATIONAL
2023-06-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Mothers will be included in the study, if they wish to participate, on day 1 or 2 following the cesarean section and a brief, structured interview will be held concerning her experience of the cesarean section.
Clinical baseline data regarding the mother, the cesarean section and the infant will be collected from patients files.
Mothers will be contacted again three months after the cesarean section, and a semi-structured interview will be held via telephone. At the end of the interview a screening for posttraumatic stress will be performed, using the PTSD-8 tool. The interviews will be recorded and transscribed verbatim.
Content of interviews will be analysed using manifest content analysis. NVivo software will be used for coding interviews.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mothers Experience of Pain Following Elective Cesarean Section. A Qualitative Study.
NCT05933993
How Well do the Current Cesarean Deliveries Adhere to the Published ERAS Guidelines?
NCT05396417
Insufficient Regional Anesthesia for Cesarean Section: Mothers' Experiences A Qualitative Study
NCT07134179
Presence of the Father During Hyperacute Cesarean Section in General Anesthesia
NCT04948892
Multiparas Attitude to Outpatient Cesarean Section
NCT05024370
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Partner present in the operation room
The partner (father, co-mother or other close relative present for the birth) is present in the operation room during the entire category 1 cesarean section. This is standard clinical practice in this particular hospital since June 2021.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Southern Denmark, Department of Regional Health Research
UNKNOWN
Sygehus Lillebaelt
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Helene Korvenius Nedergaard
MD, PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anne C Brøchner, MD, Associate Professor
Role: STUDY_CHAIR
Lillebaelt Hospital Kolding, Department of Anesthesiology and Intensive Care, and University of Southern Denmark, Department of Regional Health Research
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lillebaelt Hospital, Kolding
Kolding, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
972294863
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.